Literature DB >> 19318808

Primary cutaneous peripheral T-cell lymphoma with aberrant coexpression of CD20: case report and review of the literature.

Nicole N Balmer1, Lauren Hughey, Klaus J Busam, Vishnu Reddy, Aleodor A Andea.   

Abstract

We report an unusual case of primary cutaneous T-cell lymphoma in a 45-year-old male showing expression of the B-cell marker CD20. The lesion presented as a large plaque on the right shin and rapidly developed into additional lesions on the right lower leg and right anterior chest. Despite therapy, bone involvement was discovered at 1 year after initial presentation. Punch biopsy of the right leg revealed a diffuse, atypical dermal lymphocytic infiltrate with papillary edema and no epidermotropism. The atypical cells strongly expressed the T-cell markers CD3, CD2, and CD43, with additional expression of cytotoxic T-cell markers CD8, cytotoxic granule-associated RNA binding protein (TIA-1), and granzyme B and loss of CD7 by immunohistochemistry (IHC). In addition, the atypical cells with the above phenotype exhibited moderate expression of CD20 by IHC. Coexpression of CD8 and CD20 in the atypical cells was confirmed by a dual-labeled IHC stain. Clonal rearrangements of the T-cell receptor gamma- and beta-chain genes were detected by polymerase chain reaction; however, there was no expression of T-cell receptor beta-chain identified by IHC. In conclusion, we present a case a of CD8-positive primary cutaneous T-cell lymphoma with CD20 expression, exhibiting aggressive behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318808     DOI: 10.1097/DAD.0b013e31818cc039

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  5 in total

1.  CD20 Positive T Cell Lymphoma Involvement of Skin.

Authors:  Ki Yeol Lee; Su Young Jeon; Jin Woo Hong; Young Hun Kim; Ki Hoon Song; Ki Ho Kim
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

2.  Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides.

Authors:  Serkan Yazıcı; Emel Bülbül Başkan; Ferah Budak; Barbaros Oral; Şaduman Balaban Adim; Zübeyde Ceylan Kalin; Güven Özkaya; Kenan Aydoğan; Hayriye Saricaoğlu; Şükran Tunali
Journal:  J Immunol Res       Date:  2015-12-16       Impact factor: 4.818

3.  CD20+ cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: Case report and review of the literature.

Authors:  Amanda J Tschetter; Faraaz Zafar; Margaret S Moye; Grant K Ghahramani; Brian L Swick; Brian K Link; Vincent Liu
Journal:  JAAD Case Rep       Date:  2020-03-25

Review 4.  CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.

Authors:  Qing-ping Jiang; Shao-yan Liu; Yue-xin Yang; Xue-xian Tan; Juan Peng; Zhong-tang Xiong; Zhi Li
Journal:  Diagn Pathol       Date:  2012-10-02       Impact factor: 2.644

5.  Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review.

Authors:  Rahul G Matnani; Rachel L Stewart; Joseph Pulliam; Chester D Jennings; Melissa Kesler
Journal:  Case Rep Hematol       Date:  2013-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.